Rchr
J-GLOBAL ID:201301035910776354   Update date: Jan. 31, 2024

Riki Toita

トイタ リキ | Riki Toita
Affiliation and department:
Job title: Chief Senior Researcher
Homepage URL  (1): http://kaken.nii.ac.jp/d/r/40611554.ja.html
Research field  (7): Gastroenterology ,  Pharmaceuticals - analytical and physicochemistry ,  Regenerative dentistry and dental engineering ,  Molecular biochemistry ,  Medical systems ,  Biomaterials ,  Biomedical engineering
Research keywords  (16): 免疫 ,  炎症 ,  筋肉 ,  骨 ,  NASH ,  Pressure ulcer ,  NAFLD ,  再生医療 ,  DDS ,  バイオテクノロジー ,  ナノバイオ ,  癌 ,  MRI ,  分子イメージング ,  ナノ材料 ,  Biomaterials
Research theme for competitive and other funds  (24):
  • 2022 - 2027 The effecacy of phosphasil serine nanocareer for acute respiratory distress syndrome
  • 2023 - 2026 マクロファージ局所制御機構を有する炭酸アパタイトの開発と骨再生機能低下の克服
  • 2022 - 2025 Smart nanomedicine-mediated functional switching of macrophage and treatment of chronic kidney disease (CKD)
  • 2023 - 2025 Regenerative Therapy with Nanomedicine Capable of Reversing Chronic Inflammation into Tissue Repair Environment
  • 2021 - 2024 Macrophage-mediated reprogramming of liver microenvironment for NASH treatment
Show all
Papers (82):
  • Riki Toita, Masahiro Kitamura, Akira Tsuchiya, Jeong-Hun Kang, Shinjiro Kasahara. Releasable, Immune-Instructive, Bioinspired Multilayer Coating Resists Implant-Induced Fibrosis while Accelerating Tissue Repair. Advanced Healthcare Materials. 2023. e2302611
  • Jeong-Hun Kang, Daisuke Asai, Riki Toita. Bisphenol A (BPA) and Cardiovascular or Cardiometabolic Diseases. Journal of Xenobiotics. 2023
  • Jeong-Hun Kang, Takahito Kawano, Masaharu Murata, Riki Toita. Vascular calcification and cellular signaling pathways as potential therapeutic targets. Life sciences. 2023. 336. 122309-122309
  • Riki Toita, Jeong-Hun Kang, Akira Tsuchiya. Phosphatidylserine liposome multilayers mediate the M1-to-M2 macrophage polarization to enhance bone tissue regeneration. Acta biomaterialia. 2022. 154. 583-596
  • Riki Toita, Takahito Kawano, Masaharu Murata, Jeong-Hun Kang. Bioinspired macrophage-targeted anti-inflammatory nanomedicine: A therapeutic option for the treatment of myocarditis. Materials science & engineering. C, Materials for biological applications. 2021. 131. 112492-112492
more...
MISC (83):
  • 河野喬仁, 戸井田力, 楢原佐由子, 兵藤文紀, 赤星朋比古, 姜貞勲, 村田正治. PSリポソームによるマクロファージ機能変換と炎症性疾患の治療. 日本DDS学会学術集会プログラム予稿集. 2023. 39th
  • 姜貞勲, 村田正治, 戸井田力. マクロファージ機能変換能を有する生体材料(ナノメディシン)による炎症性疾患の治療. 日本DDS学会学術集会プログラム予稿集. 2023. 39th
  • 戸井田力, 戸井田力, 土谷享, 姜貞勲. マクロファージ表現型に着目した骨再生治療. 日本DDS学会学術集会プログラム予稿集. 2023. 39th
  • 戸井田力, 戸井田力. 炎症を標的としたマクロファージ表現型のスイッチング技術. 日本DDS学会学術集会プログラム予稿集. 2023. 39th
  • 戸井田力. Apoptotic-mimetic nanomedicines inducing M1-to-M2 macrophage polarization for medical applications: 15th Young Scientist Award, Japan Society for DDS. Drug Delivery System. 2023. 38. 5
more...
Patents (5):
Books (3):
  • Cancer targeting strategies of nanomaterials. Nanomaterials and Regenerative Medicine
    2014
  • Diagnostic and therapeutic nanomaterials that respond to cellular environments
    Studium Press 2012
  • Nanotechnological strategies for tumor-targeted delivery of drugs or genes
    Nova Publishers 2011
Education (2):
  • 2006 - 2011 Kyushu University Graduate School of Systems Life Sciences
  • 2002 - 2006 Kyushu University School of Engineering Department of Materials Science and Engineering
Professional career (1):
  • 博士(工学)
Work history (7):
  • 2023/04 - 現在 National Institute of Advanced Industrial Science and Technology
  • 2020/10 - 2023/03 National Institute of Advanced Industrial Science and Technology
  • 2016/04 - 2020/09 National Institute of Advanced Industrial Science and Technology
  • 2012/12 - 2016/03 Kyushu University Faculty of Dental Science
  • 2012/04 - 2012/11 Osaka University Graduate School of Engineering
Show all
Committee career (2):
  • 2013/06 - 2019/03 次世代医工学研究会 幹事
  • 2016/04 - 2018/09 日本生物工学会 若手会産学官連携担当委員
Awards (2):
  • 2023/07 - The Japanese Society of Drug Delivery System 15th Young Scientist Awards
  • 2010/06 - 日本分析化学会(九州支部) 九州分析化学奨励賞
Association Membership(s) (4):
THE JAPANESE SOCIETY FOR BIOMATERIALS ,  JAPANESE SOCIETY FOR CHEMICAL BIOLOGY ,  THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM ,  THE JAPANESE SOCIETY FOR REGENERTIVE MEDICINE(JSRM)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page